XQuick Search
Eastern J Med. 2020; 25(3): 461-464 | DOI: 10.5505/ejm.2020.92063
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Udayana University, Bali Indonesia
The administration of low molecular weight heparin in severe case of covid-19, a case report
Ngakan Ketut Wira Suastika1, Ketut Suega2, Putu Utami Dewi11Udayana University Hospital, Bali, Indonesia2Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Udayana University, Bali Indonesia
Coagulopathy and disseminated intravascular coagulation (DIC) is one of the complications of the corona virus disease 2019 (Covid-19) that can lead to death. Several studies have shown that anticoagulants provide good clinical outcomes in Covid-19 patients, especially in severe cases. This case emphasizes the administration of low molecular weight heparin (LMWH) to prevent venous thromboembolism (VTE) in severe case of Covid-19.
Keywords: Covid-19, coagulopathy, thromboembolism, anticoagulantCorresponding Author: Ngakan Ketut Wira Suastika, Indonesia
Manuscript Language: English
Manuscript Language: English